Search
Displaying 571–580 of 1066 results
-
AGTC Announces Results for Achromatopsia Gene Therapy Clinical Trials
Research NewsThe company will continue enrolling younger patients in higher dosing groups.
-
Virtual Workshop on Inflammation in Viral Gene Therapy of the Retina
This workshop was designed to bring together industry and academia to discuss openly what is known about the interactions of viral-mediated gene therapy of the retina with the immune system and the clinical consequences of that.
-
Eye Care Professional Resources
Contact the Foundation to receive notification of our webinars for eye care professionals and the latest updates on research and resources for inherited retinal diseases.
-
The Foundation Fighting Blindness provides valuable resources to education patients about inherited retinal diseases.
-
The Foundation’s best-in-class genetic testing program enables any eye care professional in the US to order no-cost genetic testing through the Foundation’s My Retina Tracker Program and genetic counseling for patients clinically diagnosed with an IRD.
-
The Foundation Fighting Blindness, the world’s leading private funding source for retinal degenerative disease research, will host online continuing medical education (CME and COPE) courses throughout the year. The continuing education courses will review a number of topics related to care and management of patients with inherited retinal diseases.
-
The Foundation Fighting Blindness, the world’s leading organization committed to finding treatments and cures for blinding retinal diseases, is hosts webinars to inform eye care professionals about the many opportunities to greatly enhance the quality of life, and provide hope, for their retinal disease patients.
-
The Foundation Fighting Blindness Insights Forum is a quarterly conference call providing updates to the inherited retinal disease community. The focus of this call is to report progress on the Foundation’s mission-related initiatives, highlight recent developments and provide scientific and research updates.
-
Stargazer Pharmaceuticals Initiates a Phase 2a Clinical Trial for its Stargardt Disease Drug
In the PressThe Foundation Fighting Blindness Retinal Degeneration Fund is an investor in the company
-
Positivity Always Shines Through
Beacon StoriesLinda has been blind since birth, but she never lets her visual impairments stop her from doing what she loves and staying positive through it all.
